Rankings
▼
Calendar
ZTS FY 2018 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
FY 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$5.8B
+9.8% YoY
Gross Profit
$3.8B
65.2% margin
Operating Income
$1.9B
32.3% margin
Net Income
$1.4B
24.5% margin
EPS (Diluted)
$2.93
Cash Flow
Operating Cash Flow
$1.8B
Free Cash Flow
$1.5B
Stock-Based Comp.
$53M
Balance Sheet
Total Assets
$10.8B
Total Liabilities
$8.6B
Stockholders' Equity
$2.2B
Cash & Equivalents
$1.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.8B
$5.3B
+9.8%
Gross Profit
$3.8B
$3.4B
+10.3%
Operating Income
$1.9B
$1.7B
+8.9%
Net Income
$1.4B
$864M
+65.3%
← Q4 2017
All Quarters
Q1 2018 →